NCT05000294 2026-06-05Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Recruiting29 enrolled
NCT01885949 2026-05-20Tivozanib + Enzalutamide in Adv Prostate CancerMassachusetts General HospitalPhase 2 Terminated5 enrolled 8 charts